Next Gen Biotech

Rozel 60 Injection contains Denosumab, a human monoclonal antibody that inhibits bone resorption. It is used to treat osteoporosis in postmenopausal women and men at increased risk of fractures, bone loss due to long-term steroid use, and bone loss in patients undergoing hormone therapy for certain cancers.

Esentra 120 Injection contains Denosumab, a monoclonal antibody that inhibits bone resorption. It is used to treat osteoporosis in postmenopausal women and men at increased risk of fractures. Additionally, it is prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases.

Olimab 60 Injection contains Denosumab, a human monoclonal antibody that inhibits bone resorption. It is used to treat osteoporosis in postmenopausal women and men at increased risk of fractures, as well as to manage bone loss associated with hormone ablation therapy in patients with prostate or breast cancer.